Laugesen C, Ranjan AG, Schmidt S, Norgaard K, et al. Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open-label, two-period crossover trial. Diabetologia 2023 Apr 11. doi: 10.1007/s00125-023-05909.
PMID: 37037948